Alnylam’s Givlaari wins NICE reversal after offering discount for rare genetic liver condition therapy kdunleavy Thu, 10/21/2021 – 11:20 More: Alnylam's Givlaari wins NICE reversal after offering discount for rare genetic liver condition therapy Source: fierce
read moreJohnson & Johnson preps for first CAR-T launch with a new patient support program, a dedicated sales team and more aliu Thu, 10/21/2021 – 11:16 More: Johnson & Johnson preps for first CAR-T launch with a new patient support program,
read morePfizer, Merck next-gen pneumococcal vaccines score key CDC panel’s backing on way to rival rollouts esagonowsky Thu, 10/21/2021 – 09:44 More: Pfizer, Merck next-gen pneumococcal vaccines score key CDC panel's backing on way to rival rollouts Source: fierce
read moreModerna, Johnson & Johnson COVID boosters nab FDA nods as agency backs ‘mix-and-match’ approach kdunleavy Thu, 10/21/2021 – 09:34 More: Moderna, Johnson & Johnson COVID boosters nab FDA nods as agency backs 'mix-and-match' approach Source: fierce
read moreNovartis inks deal to manufacture Pfizer COVID-19 vaccines in Slovenia jkeenan Thu, 10/21/2021 – 08:30 More: Novartis inks deal to manufacture Pfizer COVID-19 vaccines in Slovenia Source: fierce
read moreGivlaari uses ‘gene silencing’ RNA interference technology, to target the production of pathogenic compounds in people AHP More: NICE recommends gene silencing therapy for porphyria patients on NHS Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals